Topics

What’s New in Clinical Drug-drug Interaction Studies: Recommendations from Regulatory Authorities and Scientific Consortia, Upcoming Webinar Hosted by Xtalks

08:30 EDT 11 Oct 2019 | PR Web

This webinar will focus on recent scientific and regulatory developments impacting the design of clinical drug-drug interaction studies. Talking points will range from general concepts targeted towards scientists in drug development to specific recommendations from recent publications aimed at researchers directly involved in the design of clinical drug-drug interaction studies.

TORONTO (PRWEB) October 11, 2019

Join Senior Clinical Pharmacologist from Medpace, Carol Collins, MD in a live webinar on Thursday, October 24, 2019 at 11am EDT (4pm BST/UK) to learn about changes in pharmacokinetic drug-drug interaction studies.

These studies have transformed from studies of empirically-selected narrow therapeutic window and concomitantly-prescribed medications to systematic and mechanistic evaluations of a compound’s potential for interaction with key drug-metabolizing enzymes and transporters. This paradigm shift offers improved safety for participants in clinical trials and for patients after drug approval. An attractive incentive of these efforts for the industry is the development of robust in vitro systems and modelling approaches that eliminate the need for clinical drug-drug interaction studies in many cases.

Implementing these advances has been a daunting task for industry, academics and regulatory authorities. Regulators recognize the need for flexibility to accommodate an ever-expanding knowledge base in a timely manner.

This webinar will focus on recent scientific and regulatory developments impacting the design of clinical drug-drug interaction studies. Talking points will range from general concepts targeted towards scientists in drug development to specific recommendations from recent publications aimed at researchers directly involved in the design of clinical drug-drug interaction studies.

Key points to be discussed include:

  •     Timing of drug-drug interaction studies
  •     Which enzymes and transporters should be evaluated
  •     The potential role of cocktail and microdosing drug-drug interaction studies
  •     Selection of probe drugs and duration of dosing

For more information or to register for this event, visit What’s New in Clinical Drug-drug Interaction Studies: Recommendations from Regulatory Authorities and Scientific Consortia.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:
Candice Tang
Tel: +1 (416) 977-6555 ext 400
Email: ctang@xtalks.com

For the original version on PRWeb visit: https://www.prweb.com/releases/whats_new_in_clinical_drug_drug_interaction_studies_recommendations_from_regulatory_authorities_and_scientific_consortia_upcoming_webinar_hosted_by_xtalks/prweb16637893.htm

NEXT ARTICLE

More From BioPortfolio on "What’s New in Clinical Drug-drug Interaction Studies: Recommendations from Regulatory Authorities and Scientific Consortia, Upcoming Webinar Hosted by Xtalks"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...